Erik Harris - 03 Oct 2024 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
Director
Signature
/s/ Sanjay Subramanian, as attorney-in-fact for Erik Harris
Issuer symbol
INZY
Transactions as of
03 Oct 2024
Net transactions value
$0
Form type
4
Filing time
07 Oct 2024, 16:37:36 UTC
Previous filing
04 Jun 2024
Next filing
04 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INZY Stock Option (right to buy) Award $0 +56,000 $0.000000 56,000 03 Oct 2024 Common Stock 56,000 $5.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on October 3, 2024. The shares underlying the option are scheduled to vest in equal monthly installments from October 3, 2024 through October 3, 2027